Treating neurodegenerative diseases with antibiotics

Science

Volumn 307, Issue 5708, 2005, Pages 361-362

  Miller, Timothy M ^a   Cleveland, Don W ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; GLUTAMATE RECEPTOR; PENICILLIN G; RILUZOLE; ANTIINFECTIVE AGENT; BETA LACTAM; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID;

MEDICINE;

AMYOTROPHIC LATERAL SCLEROSIS; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; EXCITOTOXICITY; FOOD AND DRUG ADMINISTRATION; HUMAN; MOTOR NEURON DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; ARTICLE; BRAIN; CLINICAL TRIAL; DEGENERATIVE DISEASE; GENETICS; METABOLISM; MOTONEURON; MOUSE; PHYSIOLOGY; SPINAL CORD; SYNAPSE; SYNAPTIC TRANSMISSION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; BRAIN; CEFTRIAXONE; CLINICAL TRIALS; DRUG EVALUATION, PRECLINICAL; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; HUMANS; MICE; MOTOR NEURONS; NEURODEGENERATIVE DISEASES; SPINAL CORD; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 12344289248     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1109027     Document Type: Review

References (8)

1. J. D. Rothstein et al., Nature 433, 73 (2005).
2. M. P. Mattson, Neuromol. Med. 3, 65 (2003).
3. P. R. Heath, P. J. Shaw, Muscle Nerve 26, 438 (2002).
4. J. D. Rothstein et al., Ann. Neurol. 28, 18 (1990).
5. J. D. Rothstein et al., Ann. Neurol. 30, 224 (1991).
6. D. S. Howland et al., Proc. Natl. Acad. Sci. U.S.A. 99, 1604 (2002).
7. L. I. Bruijn et al., Annu. Rev. Neurosci. 27, 723 (2004).
8. E. J. Topol, N. Engl. J. Med. 351, 1707 (2004).